BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21515602)

  • 1. Association of the 5-aminoimidazole-4-carboxamide ribonucleotide transformylase gene with response to methotrexate in juvenile idiopathic arthritis.
    Hinks A; Moncrieffe H; Martin P; Ursu S; Lal S; Kassoumeri L; Weiler T; Glass DN; Thompson SD; Wedderburn LR; Thomson W
    Ann Rheum Dis; 2011 Aug; 70(8):1395-400. PubMed ID: 21515602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis.
    Pastore S; Stocco G; Moressa V; Zandonà L; Favretto D; Malusà N; Decorti G; Lepore L; Ventura A
    Rheumatol Int; 2015 Apr; 35(4):619-27. PubMed ID: 25240429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the ATIC 347 C/G polymorphism with responsiveness to and toxicity of methotrexate in rheumatoid arthritis: a meta-analysis.
    Lee YH; Bae SC
    Rheumatol Int; 2016 Nov; 36(11):1591-1599. PubMed ID: 27379764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism of genes involved in methotrexate pathway: Predictors of response to methotrexate therapy in Indian rheumatoid arthritis patients.
    Singh A; Gangadharan H; Gupta V; Patro PS; Misra R; Aggarwal A
    Int J Rheum Dis; 2021 May; 24(5):654-662. PubMed ID: 33780152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis.
    Dervieux T; Furst D; Lein DO; Capps R; Smith K; Walsh M; Kremer J
    Arthritis Rheum; 2004 Sep; 50(9):2766-74. PubMed ID: 15457444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients.
    Owen SA; Hider SL; Martin P; Bruce IN; Barton A; Thomson W
    Pharmacogenomics J; 2013 Jun; 13(3):227-34. PubMed ID: 22450926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of novel pharmacogenomic candidates in response to methotrexate in juvenile idiopathic arthritis: correlation between gene expression and genotype.
    Moncrieffe H; Hinks A; Ursu S; Kassoumeri L; Etheridge A; Hubank M; Martin P; Weiler T; Glass DN; Thompson SD; Thomson W; Wedderburn LR
    Pharmacogenet Genomics; 2010 Nov; 20(11):665-76. PubMed ID: 20827233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of dihydrofolate reductase (DHFR) -317AA genotype with poor response to methotrexate in patients with rheumatoid arthritis.
    Milic V; Jekic B; Lukovic L; Bunjevacki V; Milasin J; Novakovic I; Damnjanovic T; Popovic B; Maksimovic N; Damjanov N; Radunovic G; Pejnovic N; Krajinovic M
    Clin Exp Rheumatol; 2012; 30(2):178-83. PubMed ID: 22324981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variants influencing response to methotrexate in juvenile idiopathic arthritis and rheumatoid arthritis.
    Ranganathan P
    Rheumatol Int; 2016 Jan; 36(1):53-4. PubMed ID: 26156235
    [No Abstract]   [Full Text] [Related]  

  • 10. ABCB1 C3435T polymorphism influences methotrexate sensitivity in rheumatoid arthritis patients.
    Takatori R; Takahashi KA; Tokunaga D; Hojo T; Fujioka M; Asano T; Hirata T; Kawahito Y; Satomi Y; Nishino H; Tanaka T; Hirota Y; Kubo T
    Clin Exp Rheumatol; 2006; 24(5):546-54. PubMed ID: 17181924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexate.
    Lee YC; Cui J; Costenbader KH; Shadick NA; Weinblatt ME; Karlson EW
    Rheumatology (Oxford); 2009 Jun; 48(6):613-7. PubMed ID: 19193698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of methotrexate clinical response in Portuguese rheumatoid arthritis patients: implication of MTHFR rs1801133 and ATIC rs4673993 polymorphisms.
    Lima A; Monteiro J; Bernardes M; Sousa H; Azevedo R; Seabra V; Medeiros R
    Biomed Res Int; 2014; 2014():368681. PubMed ID: 24967362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATIC missense variant affects response to methotrexate treatment in rheumatoid arthritis patients.
    Kurzawski M; Malinowski D; Szarmach N; Nowak A; Goryniak A; Pawlik A; Droździk M
    Pharmacogenomics; 2016 Dec; 17(18):1971-1978. PubMed ID: 27885916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATIC 347C>G gene polymorphism may be associated with methotrexate-induced adverse events in south Indian Tamil rheumatoid arthritis.
    Muralidharan N; Mariaselvam CM; Jain VK; Gulati R; Negi VS
    Pharmacogenomics; 2016 Feb; 17(3):241-8. PubMed ID: 26799664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of genetic variants of ATP binding cassette B1, AICAR transformylase/IMP cyclohydrolase, folyl-polyglutamatesynthetase, and methylenetetrahydrofolatereductase on methotrexate toxicity.
    Sala-Icardo L; Lamana A; Ortiz AM; García Lorenzo E; Moreno Fresneda P; García-Vicuña R; González-Álvaro I
    Reumatol Clin; 2017; 13(6):318-325. PubMed ID: 27751863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in genes involved in the mechanism of action of methotrexate: are they associated with outcome in rheumatoid arthritis patients?
    Salazar J; Moya P; Altés A; Díaz-Torné C; Casademont J; Cerdà-Gabaroi D; Corominas H; Baiget M
    Pharmacogenomics; 2014 Jun; 15(8):1079-90. PubMed ID: 25084201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABCB1 and ABCC3 gene polymorphisms are associated with first-year response to methotrexate in juvenile idiopathic arthritis.
    de Rotte MC; Bulatovic M; Heijstek MW; Jansen G; Heil SG; van Schaik RH; Wulffraat NM; de Jonge R
    J Rheumatol; 2012 Oct; 39(10):2032-40. PubMed ID: 22859359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single nucleotide polymorphisms associated with methotrexate-induced nausea in juvenile idiopathic arthritis.
    Kyvsgaard N; Mikkelsen TS; Als TD; Christensen AE; Corydon TJ; Herlin T
    Pediatr Rheumatol Online J; 2021 Apr; 19(1):51. PubMed ID: 33794950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis.
    Wessels JA; van der Kooij SM; le Cessie S; Kievit W; Barerra P; Allaart CF; Huizinga TW; Guchelaar HJ;
    Arthritis Rheum; 2007 Jun; 56(6):1765-75. PubMed ID: 17530705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of polymorphisms within the methotrexate pathway genes on the toxicity and efficacy of methotrexate in patients with juvenile idiopathic arthritis.
    Yanagimachi M; Naruto T; Hara T; Kikuchi M; Hara R; Miyamae T; Imagawa T; Mori M; Kaneko T; Morita S; Goto H; Yokota S
    Br J Clin Pharmacol; 2011 Feb; 71(2):237-43. PubMed ID: 21219404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.